Lorista Losartan 50mg 30-90 tabs

Lorista Losartan Composition:
active substance: losartan; 1 film-coated tablet contains 50 mg of losartan potassium;

excipients: celactose (contains lactose and powdered cellulose), corn starch, corn starch, microcrystalline cellulose, colloidal silicon dioxide, magnesium stearate, hypromellose, talc, propylene glycol, titanium dioxide (E 171).

Pharmacotherapeutic group:
Agents acting on the renin-angiotensin system. Simple drugs of angiotensin II receptor antagonists. ATX code С09С А01.

Indications:
Treatment of essential hypertension in adults, as well as in children over the age of 6;

treatment of kidney disease in adult patients with arterial hypertension and type II diabetes mellitus with proteinuria ≥ 0.5 g / day – as part of blood pressure;

treatment of chronic heart failure (in patients over the age of 60), when the use of ACE inhibitors (ACE) is considered impossible due to incompatibility, especially when coughing or is contraindicated. Patients with heart failure, whose condition has stabilized with the use of an ACE inhibitor, should not be transferred to treatment with losartan. The patient’s left ventricular ejection fraction should be ≤ 40%, the condition should be clinically stable, and the patient should follow the established treatment regimen for chronic heart failure;

reduced risk of stroke in adult patients with arterial hypertension and left ventricular hypertrophy, documented by ECG.

Shelf life: 5 years

Produced in Slovenia